Detecting and Mitigating Group Bias in Heterogeneous Treatment Effects
异质性处理效应中的群体偏差检测与缓解AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要研究随机实验中的条件平均与群体平均处理效应,以及其偏差检验和校正,因果推断是最直接的细分方向。
异质性处理效应中的群体偏差检测与缓解AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Heterogeneous treatment effects (HTEs) are increasingly estimated using machine learning models that produce highly personalized predictions of treatment effects. In practice, however, predicted treatment effects are rarely interpreted, reported, or audited at the individual level but, instead, are often aggregated to broader subgroups, such as demographic segments, risk strata, or markets. We show that such aggregation can induce systematic bias of the group-level causal effect: even when models for predicting the individual-level conditional average treatment effect (CATE) are correctly specified and trained on data from randomized experiments, aggregating the predicted CATEs up to the group level does not, in general, recover the corresponding group average treatment effect (GATE). We develop a unified statistical framework to detect and mitigate this form of group bias in randomized experiments. We first define group bias as the discrepancy between the model-implied and experimentally identified GATEs, derive an asymptotically normal estimator, and then provide a simple-to-implement statistical test. For mitigation, we propose a shrinkage-based bias-correction, and show that the theoretically optimal and empirically feasible solutions have closed-form expressions. The framework is fully general, imposes minimal assumptions, and only requires computing sample moments. We analyze the economic implications of mitigating detected group bias for profit-maximizing personalized targeting, thereby characterizing when bias correction alters targeting decisions and profits, and the trade-offs involved. Applications to large-scale experimental data at major digital platforms validate our theoretical results and demonstrate empirical performance.
多控制变量下工资不平等界的去偏推断
We study estimation and inference for a partially identified parameter whose identified set depends on a first-stage nuisance parameter that must itself be estimated. Combining the criterion-function approach with the theory of Neyman-orthogonal moments that underlies double/debiased machine learning, we propose a two-step procedure: the point-identified nuisance is estimated by flexible machine-learning methods, and the set-identified target is recovered as a level set of a…
未观测混杂下的政策学习:稳健且有效的方法
This paper develops a robust and efficient method for policy learning from observational data in the presence of unobserved confounding, complementing existing instrumental variable (IV) based approaches. We employ the marginal sensitivity model (MSM) to relax the commonly used yet restrictive unconfoundedness assumption by introducing a sensitivity parameter that captures the extent of selection bias induced by unobserved confounders. Building on this framework, we consider…
主分层下异质性处理效应的双重交叉拟合去偏机器学习
Principal stratification provides a foundational framework for causal inference with intermediate outcomes by defining causal effects within subpopulations, yet existing work has largely focused on average effects across strata rather than treatment effect heterogeneity within strata. Such within-stratum heterogeneity informs individualized treatment decisions but the associated methods are sparse. We address this gap by studying the identification and estimation of the…
利用辅助外部数据识别治疗受益者的共形筛选框架
Identifying patients who are likely to benefit from a treatment is central to precision medicine and can guide follow-up trials, enrichment designs, and individualized decisions. Although randomized controlled trials (RCTs) provide evidence on efficacy, they are usually powered to estimate average treatment effects rather than patient-level benefit. Meanwhile, artificial intelligence and machine learning methods offer flexible tools for estimating heterogeneous treatment…
利用双重机器学习估计直接与间接分位数处理效应
We propose a framework to disentangle the quantile treatment effect of a binary treatment at a specific rank into an indirect quantile treatment effect that operates through a mediator and an unmediated direct quantile treatment effect. We establish identification results for these effects under the sequential ignorability assumption and propose double/debiased machine learning estimators, based on the efficient influence functions of the cumulative distribution functions of…
机器学习分布型工具变量估计中的模型风险
We study model risk in machine-learning estimation of the Distributional Instrumental Variable Local Average Treatment Effect (D-IV-LATE), the distributional IV effect for the subpopulation induced into treatment by the instrument. The contribution is not a new neural causal estimand. We implement a reduced-form orthogonal level-score DML estimator for the covariate-adjusted D-IV-LATE target and use it to ask how much the nuisance learner matters for distributional IV…